
image by:The Netherlands Cancer Institute
¡¡°äÅÁ»Ò¤Ë¥á¥¹¤òÆþ¤ì¡¢¥Þ¥¤¥¯¥í¥Á¥Ã¥×¤òǾ¤ËËä¤á¹þ¤à¤Û¤É¤Ë¤Þ¤Çµ»½Ñ¤¬È¯Ã£¤·¤¿¸½ºß¤Ç¤¢¤Ã¤Æ¤â¡¢¿ÍÂΤοÀÈë¤Ï¤Þ¤À¤Þ¤À´°Á´¤Ë¤Ï²ò¤ÌÀ¤«¤µ¤ì¤Æ¤¤¤Ê¤¤¡£¡¡¡ØRadiotherapy and Oncology¡Ù¡Ê2022ǯ9·î22Æü¡Ë¤Ë·ÇºÜ¤µ¤ì¤¿¸¦µæ¤è¤ë¤È¡¢¿Í´Ö¤Î¹¢¤Î±ü¤«¤é¤³¤ì¤Þ¤ÇÃΤé¤ì¤Æ¤¤¤Ê¤«¤Ã¤¿ÂñÕÁ£¤¬¶öÁ³È¯¸«¤µ¤ì¤¿¤È¤¤¤¦¡£
¹¹ð
Á°Î©Á£¤¬¤ó¤Î¸¡ºº¤Ç¶öÁ³È¯¸«
¡¡¤½¤Î¡Ö̤ÃΤΡ´ï¡×¤Ï¡¢¥ª¥é¥ó¥À¤¬¤ó¸¦µæ½ê¤Î¥°¥ë¡¼¥×¤¬¡ÖÁ°Î©Á£ÆÃ°ÛŪËì¹³¸¶¡ÊPSMA¡Ë PET-CT¡×¤È¤¤¤¦ºÇ¿·¤Î¸¡ººµ¡´ï¤ÇÁ°Î©Á£¤¬¤ó¤Î´µ¼Ô¤ò¸¡ºº¤·¤Æ¤¤¤¿¤È¤¤Ë¶öÁ³¸«¤Ä¤«¤Ã¤¿¡£¡¡PSMA PET-CT¤ÏÊü¼ÍÀ¥°¥ë¥³¡¼¥¹¤òÃíÆþ¤¹¤ë¤³¤È¤Ç¡¢¤³¤ì¤Þ¤Ç¤Ï¸«¤Ä¤±¤é¤ì¤Ê¤«¤Ã¤¿¼ðáç¤ò¸¡½Ð¤¹¤ë¤³¤È¤¬¤Ç¤¤ë¡£¤È¤³¤í¤¬¡¢¤½¤Î¸¡ºº¤Ç¤ÏÉ¡°öƬ¤Î¸å¤í¤Ëï¤âµ¤¤¬¤Ä¤«¤Ê¤«¤Ã¤¿1ÂФδﴱ¤¬É⤫¤Ó¾å¤¬¤Ã¤¿¤Î¤À¡£
¡¡¡Ö¿Í´Ö¤Ë¤ÏÂ礤ÊÂñÕÁ£¤¬3¤Ä¤¢¤ê¤Þ¤¹¤¬¡¢¤½¤Î°ÌÃ֤Ȥϰ㤦¤È¤³¤í¤Ë¤¢¤ê¤Þ¤¹¡×¤È¡¢¥ª¥é¥ó¥À¤¬¤ó¸¦µæ½ê¤Î¥¦¡¼¥¿¡¼¡¦¥Õ¥©¡¼¥Ø¥ë»á¤Ï²òÀ⤹¤ë¡£
¡¡¡Ö²æ¡¹¤ÎÃΤ뤫¤®¤ê¡¢É¡°öƬ¤Ë¤¢¤ëÂñÕÁ£¤äÇ´±ÕÁ£¤È¤¤¤¨¤Ð¡¢Ç´Ëì¤Ë1000¸Ä¤Û¤É¶ÑÅù¤Ë»¶¤é¤Ð¤Ã¤Æ¤¤¤ë¤´¤¯¾®¤µ¤Ê¤â¤Î¤Ç¤¢¤ë¤Ï¤º¤Ç¤·¤¿¡£¤Ç¤¹¤«¤é¡¢¤³¤ì¤ò¸«¤Ä¤±¤¿¤È¤¤Ï¤È¤Ë¤«¤¯¶Ã¤¤Þ¤·¤¿¡£¡×

image by:Valstar et al., Radiotherapy and Oncology, 2020
¤½¤ì¤ÏÂè»Í¤ÎÂñÕÁ£¤À¤Ã¤¿
¡¡¾Ã²½¤ËÉԲķç¤ÊÂñդϡ¢¡Ö¼ª²¼Á£¡×¡Ö³Ü²¼Á£¡ÖÀå²¼Á£¡×¤È¤¤¤¦º¸±¦¤ÇÂФˤʤä¿3¤Ä¤ÎÂ礤ÊÂñÕÁ£¤«¤é¼ç¤ËʬÈ礵¤ì¤Æ¤¤¤ë¡£¤Þ¤¿¡¢¤³¤ì¤Ë¤¯¤ï¤¨¤Æ¡¢¸ý¹Ð¤ä¾Ã²½´É¤Ë¤ÏÌܤ˸«¤¨¤Ê¤¤¤Û¤É¾®¤µ¤ÊÂñÕÁ£¤¬1000¸Ä¤Û¤É»¶¤é¤Ð¤Ã¤Æ¤¤¤ë¡£¡¡É¡¤Î¸å¤í¡¢¸ý³¸¤Î¾å¤Î¤¢¤¿¤ê¤Ç¸«¤Ä¤«¤Ã¤¿ÂñÕÁ£¤Ï¡¢PSMA PET-CT¸¡ºº¤ò¼õ¤±¤¿100¿ÍÁ´°÷¤Ç¸¡½Ð¤µ¤ì¤Æ¤ª¤ê¡¢2ÂΡÊÃ˽÷¡Ë¤Î¸¡ÂΤβò˶¤Ë¤è¤Ã¤Æ¤â¡¢½ÄĹ¤Î´ï´±¤ÈÉ¡°öƬÊɤؤऱ¤Æ³«¤¤¤¿´É¤¬³Îǧ¤µ¤ì¤¿¡£
¡¡¤Þ¤¿Á£ÁÈ¿¥¤¬´Þ¤Þ¤ì¤Æ¤¤¤ë¤³¤È¤â³Îǧ¤µ¤ì¤Æ¤ª¤ê¡¢¤É¤¦¤ä¤é4¤ÄÌܤμçÍפÊÂñÕÁ£¤Ç¤¢¤ë¤È¹Í¤¨¤é¤ì¤ë¤è¤¦¤À¡£¸¦µæ¤Îȯɽ»þÅÀ¤Ç¤Ï¡¢¼ª´Éδµ¯¤È¤¤¤¦Æð¹ü¤Î¾å¤Ë¤¢¤ë¤³¤È¤«¤é¡Ö¼ª´ÉÁ£¡Êtubarial glands¡Ë¡×¤È¤¤¤¦Ì¾¾Î¤¬Ä󰯤µ¤ì¤Æ¤¤¤ë¡£

image by:Valstar et al., Radiotherapy and Oncology, 2020
Êü¼ÍÀþ¼£ÎŤǤÏÃí°Õ¤¬É¬Í×
¡¡¤³¤ì¤Þ¤Çȯ¸«¤µ¤ì¤Ê¤«¤Ã¤¿¤Î¤Ï¡¢Æ¬³¸¹ü¤Î²¼¤Î´Êñ¤Ë¤ÏÇÁ¤±¤Ê¤¤Éô°Ì¤Ë±£¤ì¤Æ¤¤¤ë¤³¤È¤¬¸¶°ø¤Ç¤¢¤ë¤é¤·¤¤¡£¡¡Æâ»ë¶À¤òÆþ¤ì¤¿¤È¤¤Ë´É¤Î³«¸ýÉô¤Ëµ¤¤Å¤¯²ÄǽÀ¤Ï¤¢¤ë¤½¤¦¤À¤¬¡¢¤Þ¤µ¤«ÂñÕÁ£¤À¤È¤Ï»×¤ï¤ì¤º¡¢¤³¤ì¤Þ¤Ç¸«²á¤´¤µ¤ì¤Æ¤¤¿¤è¤¦¤À¡£
¡¡¤Ê¤ªÂñÕÁ£¤ÏÊü¼ÍÀþ¤ËÈó¾ï¤Ë¼å¤¤¤¿¤á¤Ë¡¢º£¸å¡¢Æ¬Éô¤ÎÊü¼ÍÀþ¼£ÎŤò¹Ô¤¦ºÝ¤Ë¤Ï¡¢¤³¤ì¤òÈò¤±¤ë¤è¤¦Ãí°Õ¤¬É¬Íפˤʤë¤À¤í¤¦¤È¤Î¤³¤È¡£
¡¡¼ÂºÝ¡¢²áµî¤ÎÊü¼ÍÀþ¼£ÎŤΥǡ¼¥¿¤«¤é¤Ï¡¢¼ª´ÉÁ£¤¬¤¢¤ëÉô°Ì¤ËÊü¼ÍÀþ¤òÅö¤Æ¤ë¤È¡¢¹çÊ»¾É¤¬½Å¤¯¤Ê¤ë·¹¸þ¤¬¸«¤Æ¼è¤ì¤ë¤½¤¦¤À¡£
Cancer researchers discover new salivary gland
The tubarial salivary glands: A potential new organ at risk for radiotherapy - Radiotherapy and Oncology
https://www.thegreenjournal.com/article/S0167-8140(20)30809-4/fulltextReferences:livescience / sciencealert¤Ê¤É/ written by hiroching / edited by parumo
Äɵ¡§2020ǯ10·î¤Îµ»ö¤òºÆÁ÷¤·¤Æ¤ªÆÏ¤±¤·¤Þ¤¹¡£
¤¢¤ï¤»¤ÆÆÉ¤ß¤¿¤¤





¥³¥á¥ó¥È
1. ƿ̾½èÍýÈÉ
¡ÖÁ°Î©Á£´â¤Î¸¡ºº¤ò¤·¤Æ¤¤¤¿¤é¡¼¡¢¤Ê¤ó¤ÈÉ¡¤Î±ü¤ËÂñÕÁ£¤ò¸«¤Ä¤±¤Æ¤·¤Þ¤Ã¤¿¡¼¡£¤É¤¦¤·¤è¡¼¡×
¡ÖÁ¬·Á¤á¡¢¤ï¤¶¤È¤é¤·¤¤¿¿»÷¤ò ! ¡×
2. ƿ̾½èÍýÈÉ
Á´Éô¸«¤Ä¤±¤é¤ì¤¿¤«¤Ê¡©
3. ƿ̾½èÍýÈÉ
²¿¤ÇÁ°Î©Á£´â¤ÇÂñÕÁ£¡©¤È»×¤Ã¤Æ¤¤¤¿¤±¤É¡¢¼ðáç¤Îž°Ü¤È¤«Ä´¤Ù¤Æ¤¤¤¿¤Î¤«¤Ê¡©
4. ƿ̾½èÍýÈÉ
ÅöÊý¤Þ¤¸¤á¤Ë»õ°å¼Ô¡£
¿©»ö¡Ê¤¿¤À¤·¤¦¤Þ¤¤¤ä¤Ä¤Ë¸Â¤ë¡Ë¤À¤ÈÀΤ«¤éÉ¡¹Ð¤«¤é¤Ê¤ó¤«½Ð¤Æº¤¤Ã¤Æ¤¿
¡Ê¤Þ¤¡É¡¿å¤È¤ª¤â¤Ã¤Æ¤¿¤ó¤À¤«¡Ë
º£²óÂñÕÁ£¤Î°ì¼ï¤Èʬ¤«¤Ã¤Æ¤¢¤ë°ÕÌ£¤¹¤´¤¤Ç¼ÆÀ¤·¤Æ¤¤¤Þ¤¹
5. ƿ̾½èÍýÈÉ
¤Û¤ó¤È¤¦¤Ë"¸«Æ¨¤µ¤ì¤Æ¤¤¿"¤Î¤«¡©
¼Â¤ÏºÇ¶á¤Ë¤Ê¤Ã¤Æ¤½¤¦¤¤¤¦¥Ë¥ó¥²¥ó¤¬Áý¤¨¤Æ¤¤¿¡¢¤È¤¤¤¦¤À¤±¤«¤â¤·¤ì¤ó¤¾¤è¡©
ǯÎ𤴤ȤËÄ´¤Ù¤¿¤é¤¢¤ë°ìÄêǯÎð°Ê²¼¤Î¿Í´Ö¤Ë¤·¤«¸«¤Ä¤«¤é¤Ê¤¤¤«¤â¤·¤ì¤Ê¤¤
6. ƿ̾½èÍýÈÉ
¤½¤ì¤Ç¡¢Âè»°¤ÎÌܤÎÊý¤Ï¡¢¤É¤³¤Ë¤¢¤ë¤ó¤Ç¤·¤ç¤¦¤«¡Ê¾Ð¡Ë
7. ƿ̾½èÍýÈÉ
>>4
¤¨¡©¡¡(*_*)¡¡¤½¤ì¤¸¤ã¥é¡¼¥á¥ó¤ò¿©¤Ù¤¿»þ¤Î¥¢¥ì¤Ã¤Æ¡Ä¡Ä¥³¥ì¤Ç¤·¤ç¤¦¤«¡©
8. ƿ̾½èÍýÈÉ
¸åɡϳ¤Î¸¶°ø¤Ã¤Æ¥³¥ì¤«¤Í¡£¶µ¤¨¤Æ°å³Ø¤Î¿Í
9. ƿ̾½èÍýÈÉ
¤¨¡¼!! ¤¹¤´¤¤¡¢¤½¤³¤½¤³¤ÎÂ礤µ¤Ï¤¢¤ë´¶¤¸¤Ê¤Î¤Ë¡¢
¤Þ¤À¿ÍÂΤǤ½¤ó¤Ê̤ȯ¸«¤ÎÉô°Ì¤¬¤¢¤Ã¤¿¤ó¤À¡ª
10. ƿ̾½èÍýÈÉ
¤Û¤¢¡¼¡ª
²¿ÀéËü¤È°å³ØÏÀʸ¤¬½Ð¤ë¤è¤¦¤Ê»þÂå¤Ë
º£¤Îº£¤Þ¤ÇÃΤé¤ì¤Æ¤¤¤Ê¤¤´ï´±¤¬¤¢¤Ã¤¿¤Ê¤ó¤Æ¡Ä
¿Í´Ö¤Î¥Ñ¡¼¥Ä¤Ë¤Ï¤â¤¦Á´Éô̾Á°¤¬¤Ä¤¤¤Æ¤ë¤â¤ó¤À¤È»×¤Ã¤Æ¤¿¤ï
11. ƿ̾½èÍýÈÉ
¿ÀÈë¡£²¶¤Ë¤â±£¤ì¤¿Ç½ÎϤ¬¤¢¤ë¤«¤â¤·¤ì¤ó¡£
12. ƿ̾½èÍýÈÉ
¹¢¤Ã¤Æ¤¤¤¦¤«¤é¹¢Ê©¤¢¤¿¤ê¤Ë¤¢¤Ã¤¿¤Î¤«¤È»×¤Ã¤¿¤é
¤Û¤ÜÉ¡¹Ð¤Ç¤¹¤Í¤³¤ì¤Ï
¤Ê¤ó¤«Â¾¤Ë¤âÃΤé¤ì¤Æ¤Ê¤¤´ï´±¤¢¤ê¤½¤¦¤À¤Ê¤Ã¤Æ¤Ê¤Ã¤Æ
õ¤·»Ï¤á¤ë¸¦µæ¼Ô¤±¤Ã¤³¤¦¤¤¤½¤¦
13. ƿ̾½èÍýÈÉ
>>5
100¿Í¸¡ºº¤·¤ÆÁ´°÷¤Ë¸«¤Ä¤«¤Ã¤¿¤Ã¤Æ½ñ¤¤¤Æ¤¢¤ë¤ä¤í
Îã³°¤¬1¿Í¤Ç¤â¤¤¤ì¤Ð¤È¤â¤«¤¯º£¤Î¤È¤³¤íï¤Ë¤Ç¤â¤¢¤ë¤Ê¤é¤ò¤ì¤ÏÉáÄ̤ˤ¢¤ë¤Ã¤Æ»ö¤ä¤í
14. ƿ̾½èÍýÈÉ
100ǯÁ°¤Ê¤é¤È¤â¤«¤¯¡¢¿Í´Ö¤ÎÂΤʤó¤ÆÀ¸¤¤¿¾õÂ֤Ƿì´É¤â´Þ¤á¤ÆÁ´¤Æ»°¼¡¸µÅª¤Ë·×¬¤Ç¤¤ëº£¤Î»þÂå¤Ë¸«Íî¤È¤·¤¿¤¢¤Ã¤¿¤Î¤Ï¶Ã¤¡£
Áǿͤ«¤é¤¹¤ì¤Ð¡´ï¤Ê¤ó¤ÆÁ´Éôȯ¸«ºÑ¤ß¤À¤È»×¤Ã¤Æ¤¿
15. ƿ̾½èÍýÈÉ
>>6
º£¼«Ê¬¤ÎÂθ«¤Æ¤ß¤¿¤é¤¢¤ê¤Þ¤·¤¿¡ª
16. ƿ̾½èÍýÈÉ
̤ȯ¸«¤Î´ï´±¤Ê¤ó¤Æ¤¢¤ë¤Ï¤º¤¬¤Ê¤¤¡¢¤Ã¤Æ¤¤¤¦¥Ð¥¤¥¢¥¹¤â¤³¤ì¤Þ¤Ç¸«¤Ä¤«¤é¤Ê¤«¤Ã¤¿¸¶°ø¤«¤â¤Í
17. ƿ̾½èÍýÈÉ
>>6
¾¾²ÌÂΤäÁ¤å¡¼¤Î¤¬Âಽ¤·¤¿¤½¤ì¤À¤Ã¤ÆÊ¹¤¤¤¿»ö¤¢¤ë¤Ê¡£
18. ƿ̾½èÍýÈÉ
¿ôÆüÁ°¤Ë¥ä¥Õ¡¼¥Ë¥å¡¼¥¹¤Ç¸«¤¿»þ¤Ï¡¢Ì¤ÃΤΡ´ïȯ¸«¤Ã¤Æ¤¢¤Ã¤¿¤±¤ÉÂñÕÁ£¤ÎÃç´Ö¡©¤À¤Ã¤¿¤È¤Ï¡ª
19. ƿ̾½èÍýÈÉ
ÈÓ¤ò¿©¤Ã¤¿»þ¡¢¤¢¤ë¤¤¤Ï¿©¤Ã¤¿¸å¤Ë¡¢É¡¿å¤¬½Ð¤ëÍýͳ¤¬¥³¥ì¤« ?
20.
21. ƿ̾½èÍýÈÉ
¢¨13
Á´À¤³¦¤Ç¤½¤Î100¿Í¤Ë¤·¤«¤Ê¤¤¤Î¤«¤â¤è
22. ƿ̾½èÍýÈÉ
¤Ê¤ó¤«Æ¬Äˤ¤¤Î¤¬¼£¤ë¤È¤
É¡¤Î±ü¤Ç²¿¤«É¡¿å¤È°ã¤¦¤Î¤¬½Ð¤Æ¤¯¤ë´¶¿¨¤¬¤¢¤Ã¤Æ¤½¤ì¤¬½Ð¤ë¤È¼£¤ë¤Î¤Í
¤³¤ì¤Ê¤Î¤«¤Ê
23. ƿ̾½èÍýÈÉ
¢¨13
¡Ö¤¿¤Þ¤¿¤ÞÁª¤ó¤À100¿Í¤¬Á´°÷¡¢ÄÁ¤·¤¯Âè4¤ÎÂñÕÁ£¤¬¤¢¤ë¿Í¤¿¤Á¤À¤Ã¤¿¡×¤È¤¤¤¦²ÄǽÀ¤â¡Ä
¡Ä¤¹¤¤¤Þ¤»¤ó¡¢¸À¤Ã¤Æ¤ß¤¿¤À¤±¤Ç¤¹¡£
24. ƿ̾½èÍýÈÉ
>>13
100¿Í¸¡ºº¤·¤ÆÁ´°÷¤Ë¸«¤Ä¤«¤Ã¤¿¤Ã¤Æ½ñ¤¤¤Æ¤¢¤ë¤Î¤Ï¤Á¤ã¤ó¤ÈÆÉ¤ó¤À¾å¤Ç>>5¤Î¥³¥á¥ó¥È¤ò¤·¤¿¤ó¤À¤è¡£¤½¤ì¤Ëµ»ö¤Ë¤â¡Ø¡Ä¤È¹Í¤¨¤é¤ì¤ë¤è¤¦¤À¡Ù¤È½ñ¤«¤ì¤Æ¤¤¤ë¤è¤¦¤Ë¡¢ÉáÄ̤Ëï¤Ë¤Ç¤â¤¢¤ë¤ÈÃÇÄê¤Ï¤µ¤ì¤Æ¤¤¤Ê¤¤¤ó¤À¡£
¸µÏÀʸ¤Ë¤Ï100¿Í¤ÎÆâÌõ¤¬½Ð¤Æ¤¤¤Æ¡¢2017ǯ°Ê¹ß¤ÎÁ°Î©Á£´â¤â¤·¤¯¤ÏǢƻ´â¤Ë¤«¤«¤Ã¤ÆPSMA PET/CT¸¡ºº¤ò¼õ¤±¤¿´µ¼Ô¡¢Ï¢Â³¤·¤Æ100̾¤Î¸¡ºº²èÁü¤òNCI¡ÊNetherland Cancer Institute¡Ë¤«¤éÄ󶡤·¤Æ¤â¤é¤Ã¤ÆÊ¬ÀϤ·¤¿¤ß¤¿¤¤¤À¡£Ç¯Îð¤Ï53ºÐ¤«¤é84ºÐ¡¢ÃËÀ99¿Í½÷À1¿Í¤È¤¤¤¦¤³¤È¤é¤·¤¤¡£
Á´¿ÍÎà¤òÄ´¤Ù¤Ê¤¤¸Â¤êǧ¤á¤Ê¤¤¤Ê¤ó¤Æ¸À¤¦¤Ä¤â¤ê¤Ï¤Ê¤¤¤±¤É¡¢¤³¤Î¸¦µæ¤ÎÄ´ººÂоݤˤϤä¤Ï¤êÊФ꤬¤¢¤ë¤·¡¢¤Ê¤Ë¤è¤ê¸µÏÀʸ¤ÎÃø¼Ô¤¿¤Á¤â"100¿ÍÎã³°¤Ê¤¯¤¢¤ë¤«¤éÉáÄ̤ˤ¢¤ë"¤È¤ÏÃǸÀ¤·¤Æ¤Ê¤¤¤ó¤À¡£¤½¤ì¤è¤ê¤â¡¢¤³¤³¤ËÂñÕÁ£¤¬¤¢¤ë¤³¤È¤ò¹Íθ¤·¤ÆÊü¼ÍÀþ¼£ÎŤΤä¤êÊý¤òÊѤ¨¤ì¤Ðº£¸å¤Î´µ¼Ô¤ÎQOL¤ò¸þ¾å¤Ç¤¤ë¤«¤â¤·¤ì¤Ê¤¤¡¢¤È¤¤¤¦Ïäò¤·¤Æ¤¤¤ë¤ß¤¿¤¤¤À¤è¡£ÆüËܤˤâÊÆ¹ñ¤Ë¤â´â¥»¥ó¥¿¡¼¤Ï¤¢¤Ã¤Æ²áµî¤Î¸¡ºº²èÁü¤Î¥¹¥È¥Ã¥¯¤Ï¤¢¤ë¤À¤í¤¦¤·¡¢ËÜÅö¤Ë"ï¤Ë¤Ç¤â¤¢¤ëÂè4¤ÎÂñÕÁ£"¤Èǧ¤á¤é¤ì¤ë¤«¤É¤¦¤«¤Ï¤³¤ì¤«¤é¤¸¤ã¤Ê¤¤¤«¤È»×¤¦¤ó¤À¡£¤½¤ì¤Ë¡¢¿Í´Ö¤Ï¤ß¤ó¤ÊÊ¿¶Ñ¿ÈŤäÌܤ理À¤Ã¤ÆÃϰè¤äǯÂå¤Ë¤è¤Ã¤ÆÊѤï¤Ã¤Æ¤¤¿¤È¤¤¤¦¤·¡¢¤¿¤È¤¨¤ÐÃæÀ¤¤Î¿Í¤Ë¤ÏËØ¤Éȯ㤷¤Æ¤Ê¤«¤Ã¤¿ÂñÕÁ£¤È¤¤¤¦²ÄǽÀ¤À¤Ã¤Æ¤¢¤ë¤«¤â¤·¤ì¤Ê¤¯¤Æ¡¢¤â¤·¤½¤¦¤Ê¤éÌÌÇò¤¤¤«¤â¤Ê¤È»×¤Ã¤¿¤ó¤À¤è¡£
25. ƿ̾½èÍýÈÉ
>>14
¤Á¤ç¤Ã¤È¶Ã¤¤À¤±¤É¡¢£Í£Ò£É¸¡ºº¤Ç¤â£Ã£Ô¸¡ºº¤Ë¤â¡¢½Ð¤Æ¤³¤Ê¤¤´ï´±¤À¤Ã¤¿¤ó¤À¤Ã¤Æ¡£
Êü¼ÍÀ¤Î¤±ÆºÞ¸¡ºº¤·¤Æ¡¢½é¤á¤Æ¸«¤Æ¡Ö¤Ê¤ó¤À¥³¥ì¤Ï¡©¡©¡×¤È¤Ê¤Ã¤¿¤é¤·¤¤¡£
¤ª¤½¤é¤¯¤Ïº£¤Þ¤Ç¤âƱÍͤθ¡ºº¤Ç¸«¤¨¤Æ¤¿¤í¤¦¤±¤É¡¢¶½Ì£»ý¤¿¤ì¤Ê¤«¤Ã¤¿¤ó¤Ç¤·¤ç¤¦¤Í¡£
26. ƿ̾½èÍýÈÉ
´ù¤ËÆÍ¤ÃÉú¤·¤Æ¿²¤Æ¤ë¤È¤¿¤Þ¤Ë¥µ¥é¥µ¥é¤ÎÉ¡¿å¤¬½Ð¤Æ¤¯¤ë¤³¤È¤¬¤¢¤Ã¤¿¤¬¤³¤ì¤¬¸¶°ø¤À¤í¤¦¤«
27. ƿ̾½èÍýÈÉ
¼ª¤«¤é¿å¤¬½Ð¤ë¿Í¤Ã¤Æ¤³¤ì¤È´Ø·¸¤¢¤ë¤Î¤«¤Í
28. ƿ̾½èÍýÈÉ
¢¨13¡¡¿Í¼ï¤Ë¤è¤ë°ã¤¤¤¬¤¢¤ë¤«¤â¤·¤ì¤Ê¤¤¡£¤Ê¤¤¤«¤â¤·¤ì¤Ê¤¤¤±¤É¡£
29. ƿ̾½èÍýÈÉ
¿Í´Ö¤ÏǾ¤¬µðÂç²½¤·¤ÆÆ¬¤¬90ÅÙÀÞ¤ì¶Ê¤¬¤Ã¤¿¤«¤é
°ìÈÖ±ü¤ÎÂñÕÁ£¤¬ÊѤʤȤ³¤í¤ËÆþ¤ê¹þ¤ó¤¸¤ã¤Ã¤Æ¤ë¤ó¤À¤Ê
30. ƿ̾½èÍýÈÉ
Êü¼ÍÀ¥°¥ë¥³¡¼¥¹¤Ê¤ï¤±¤Í¡¼¤À¤í¡£
PSMA-PET¤Ã¤Æ¤Á¤ã¤ó¤È½ñ¤¤¤Æ¤¤¤ë¤À¤í¡£
PSMA¥ê¥¬¥ó¥É¤ËÊü¼ÍÀʪ¼Á¤ò¤¯¤Ã¤Ä¤±¤Æ¸¡½Ð¤·¤¿¤«¤é¸«¤Ä¤«¤Ã¤¿¤ï¤±¤À¤í¡©
¤½¤³¤¬¿·¤·¤¤¤ó¤À¤«¤é¡¢¤½¤³¤ò½ñ¤±¡ª
ÆüËܤÀ¤±5ǯ°Ê¾åÃÙ¤ì¤Æ¤Æ¡¢ÂԤäƤë¿Í¤¬¤´¤Þ¤ó¤È¤¤¤ë¤ó¤À¤¼¡©
ÏÀʸ¤Ë¤Ï´Ø·¸¤Ê¤¤¤¬¡¢²¾¤Ë½¾Íè¤Î£Æ£Ä£Ç¤Î»ö¤ò¤¤¤¤¤¿¤¤¤Ê¤é
Êü¼ÍÀ¥°¥ë¥³¡¼¥¹¥¢¥Ê¥í¥°¤À¤í¡£
ÏÀʸÆÉ¤ó¤Ç¤«¤éµ»ö½ñ¤±¡£
¼ª´ÉÁ£¤ÎÌõ¤â¤¤¤Þ¤¤¤Á¤À¤·¡£¥»¥ó¥¹¤¬¤Ê¤¤¡£¡£
31. ƿ̾½èÍýÈÉ
>>7
¤½¤ì¤Ï¥é¡¼¥á¥ó¤ÎÅòµ¤¤À¤È»×¤¦¤±¤É¡Ä
32. ƿ̾½èÍýÈÉ
¢¨3
PET-CT¤Ï¥È¥ì¡¼¥µ¡¼¤È¤¤¤¦Êü¼ÍÀʪ¼Á¤ò´Þ¤ó¤ÀÌôºÞ¤òÅêÍ¿¤·¤Æ¡¢
CT²èÁü¤Ë¡¢PET¤Ç»£±Æ¤·¤¿Êü¼ÍÀʪ¼Á¤ÎʬÉÛ¤ò½Å¤Í¹ç¤ï¤»¤Æ´Ñ»¡¤Ç¤¤ë¡£
ÌôºÞ¤Ï¡¢ÂñÕÁ£¡¢ÃÀÆ»¡¢Ä²´É¡¢Ç¢Ï©¤Ê¤ó¤«¤ò·Ðͳ¤·¤ÆÂг°¤ËÇÓÝõ¤µ¤ì¤ë¤«¤é¡¢
PET¤ò»£±Æ¤·¤¿»þ¤Ë¡¢¤³¤¦¤¤¤¦Â¡´ï¤Ë¤Ïɵ¤¤¸¤ã¤Ê¤¤¤±¤ÉÌôºÞ¤Î¿®¹æ¤¬¤ß¤¨¤ë¤â¤Î¤Ê¤Î¡£
33. ƿ̾½èÍýÈÉ
¤³¤Î¥Ë¥å¡¼¥¹¤Ë¤ÏËÜÅö¤Ë¶Ã¤¤¤¿¡£
¤Þ¤À¤½¤¦¤¤¤¦´ï´±¤¬¤¢¤ë¤Î¤À¤í¤¦¤«¡£
34. ƿ̾½èÍýÈÉ
¤³¤ì¤Î¸ºß¤¬Ç§¼±¤µ¤ì¤Æ¤³¤Ê¤«¤Ã¤¿¤»¤¤¤Ç¸¶°øÉÔÌÀ¤ÇÊÒÉÕ¤±¤é¤ì¤¿¤ê¸«Åö°ã¤¤¤Î¼£ÎŤDzþÁ±¤»¤ºÇº¤ó¤Ç¤ë¿Í¤â¤¿¤¯¤µ¤ó¤¤¤½¤¦
¤³¤Îȯ¸«¤¬Á᤯¸½¾ì¤Ë¹Ô¤ÅϤë¤È¤¤¤¤¤±¤É¡¢ºÇ¿·¤ÎÃθ«¤ä¼£ÎÅË¡¤Ã¤Æ¿»Æ©¤¹¤ë¤Î¤Ë¤¹¤´¤¤»þ´Öº¹¤¬¤¢¤Ã¤Æ¡¢¥Á¥§¥Ã¥¯¤·¤Ê¤¤°å¼Ô¤Ï¤¤¤Ä¤Þ¤Ç¤â¥¹¥ë¡¼¤À¤Ã¤¿¤ê¤¹¤ë¤«¤é¤Ê
¡ÊÊÌ·ï¤À¤±¤É¼«Ê¬¤â¤½¤ì¤Ç¤Ç¶ìÏ«¤·¤¿¤Î¤Ç¡Ë
35. ƿ̾½èÍýÈÉ
¤Þ¤¨¤â¤Ê¤ó¤«É¡¤Î±ü¤Ë¤¢¤Ã¤ÆÉ¡¸ÆµÛ¤·¤¿»þ¤À¤±»ÀÁǤòÊѲ½¤µ¤»¤ë
¡Ê¤Ê¤Î¤ÇĹ´üŪ¤Ë¸ý¸ÆµÛ¤ÏÌäÂ꤬½Ð¤ë¡Ë¡´ï¤¬¸«¤Ä¤«¤Ã¤Æ¤Ê¤«¤Ã¤¿¤«¡©
36. ƿ̾½èÍýÈÉ
>>6
²¶¤Î¼Ù´ã¤¬áÖ¤¯
37. ƿ̾½èÍýÈÉ
¾å°öƬ±ê¤ä¤Ê
38. ƿ̾½èÍýÈÉ
¤½¤ÎÊÕ¤¿¤Þ¤Ë¥Ò¥ê¥Ò¥êÄˤ¯¤Ê¤ë
39. ƿ̾½èÍýÈÉ
µîǯ¤«°ìºòǯ¤¯¤é¤¤¤Ë¤âƱ¤¸¤è¤¦¤Ë¡Ö¤Ê¤ó¤Çº£¤Þ¤Çµ¤ÉÕ¤«¤Ê¤«¤Ã¤¿¡×¤Ã¤ÆÈ¯¸«¤¬¤¢¤Ã¤Æ¤³¤³¤Ç¤â¼è¤ê¾å¤²¤é¤ì¤Æ¤¿µ¤¤¬¤¹¤ë¤«¤é¡¢»×¤¤¹þ¤ß¤Ç¸«Íî¤È¤µ¤ì¤Æ¤ë¤±¤É¼Â¤Ï¤Þ¤µ¤«¤Î̤³Îǧ¤Ã¤Æ¥Ñ¡¼¥Ä¤¬¤Þ¤À¤¢¤ê¤½¤¦
³Æ²Ê¤ÎÀìÌç°å½¸¤á¤Æ°ìÀƾȹ礷¤¿¤é¸«¤Ä¤«¤ë¤ó¤¸¤ã¤Ê¤¤¡©